Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial

Fig. 2

Overview of all time-dependent endpoints. QAPFS   Quality-adjusted Progression Free Survival, Q-TWiST   Quality-adjusted Time Without Symptoms and Toxicity, TOX   Toxicity, TWIST   Time Without Symptoms and Toxicity, REL  Relapse, PFS   Progression Free Survival, OS   Overall Survival

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us